AGENDA
Basel, 8 - 10 November 2022
Schedule
Create your personal agenda –check the favourite icon
Nov 88:40
Conference pass
Unlocking the power of data science to change the trajectory of human health
Keynotes
Najat Khan, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Research & Development
Nov 88:55
Conference pass
Chair Remarks
Plenary - Genomics Live
Slave Petrovski, VP, Centre for Genomics Research, AstraZeneca
Nov 89:00
Conference pass
Bringing Data, Digital and Technology into Research & Development
Keynotes
Anne Heatherington, Head, Data Sciences Institute and R&D Chief Data & Technology Officer, Takeda
Nov 89:00
Conference pass
Large-scale data collaboration across industry and public sector: Creating a gold standard reference repository of genetic data to fuel medical research
Plenary - Genomics Live
Sebastian Wasilewski, Senior Director, Genome Informatics, AstraZeneca
Nov 89:40
Conference pass
Fostering entrepreneurship in pharma to drive innovation across genomics, data science and digital health
Plenary - Genomics Live
Nadeem Sarwar, Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies, Eisai
Nov 810:00
Conference pass
Panel Discussion - Illumina
Plenary - Genomics Live
Gregg Talbert, Senior Vice President, Head of Personalized Healthcare and Digital Partnering, Roche
Nov 810:00
Conference pass
Panel Discussion: How Data Centric approaches are transforming the Life Sciences Industry?
Keynotes
Bérénice Wulbrecht, VP Solution Delivery, ONTOFORCE
Najat Khan, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Research & Development
Faisal Khan, Corporate Vice President, Advanced Analytics, AI & RWD, Novo Nordisk
Mahesh Pancholi, Chief Information Officer, UK Biobank
Ravi Prasad, Global Head, Data and AI Stratergy and Operations, Novartis
Angeli Moller, Head of Pharma International Informatics (PIIX), Roche
Nov 811:40
Conference pass
Chair remarks
Image Analysis
Mishal Patel, Global Head of Imaging, AI & Data Analytics, AstraZeneca
Nov 811:40
Conference pass
Chair remarks
AI in Drug Development
Neel Madhukar, Chief Executive Officer, OneThree Biotech
Nov 811:40
Conference pass
Chair remarks
NLP
Darryl Davis, Senior Director, AstraZeneca
Nov 811:40
Conference pass
Chair remarks
Big Data in Oncology
Amrik Mahal, Global IT Head for Research, AstraZeneca
Nov 811:40
Conference pass
Chair remarks
Analytics Platforms
Daniel Butnaru, Head of Scientific Solution Engineering & Architecture, Roche
Nov 811:40
Conference pass
Chair remarks
Data Integration + FAIR
Felipe Albrecht, Senior Scientist, Discovery Informatics, Lab Automation & Data Handling, Roche
Nov 811:40
Conference pass
Chair remarks
Bioinformatics +In Silico R&D
Angelina Irizari Policarpio, Head of U.S. HEOR and RWE Communications Team (Market Access), Eisai
Nov 811:40
Conference pass
Chair remarks
Data Management, Storage and Architecture
Dan Paulson, Senior Enterprise Architect, AstraZeneca
Nov 811:40
Conference pass
Chair remarks
Digital Transformation
Cindy Novak, Sr Manager, BMS
Nov 811:40
Conference pass
Chair remarks
RWE
Khaled Sarsour, Vice President of Real-World Evidence (RWE) Analytics and Insights, Janssen R&D
Nov 811:40
Conference pass
Chair remarks
Single Cell Genomics
Caroline Gubser Keller, Global Head Chemical Biology & Therapeutics Data Science, Novartis Institutes for Biomedical Research
Nov 811:40
Conference pass
Chair remarks
Liquid Biopsy
Hakan Sakul, Vice President And Head Of Diagnostics, Pfizer
Nov 811:40
Conference pass
Chair remarks
Companion Diagnostics
Christian Ruiz, Head Diagnostic Laboratory Department, Co-Director Research Department Pathology, University Hospital Basel, Medical Genetics & Pathology
Nov 811:40
Conference pass
Chair remarks
Population Genomics
Thomas Hach, Executive Director, Patient Engagement Cardiovascular, Renal & Metabolism, Novartis
Nov 811:45
Conference pass
Exploring the role of image analysis in predictive biomarkers
Image Analysis
Radha Krishnan, Executive Director, Clinical Pathology Lead, MSD
Nov 811:45
Conference pass
Machine learning to identify adverse effects in scientific literature
AI in Drug Development
Sonja Wewering, Director, Digital Literature Screening Leader, Bayer
Nov 811:45
Conference pass
Meaning based computing beyond NLP: Integration of text-based information in digital business for faster knowledge transfer
NLP
Cedric Berger, Head of Knowledge Extraction & Integration, Roche
Nov 811:45
Conference pass
Doing more with less - how ML/AI guides compound design in early drug discovery
Cheminformatics
Daniel Kuhn, Associate Director, Merck
Nov 811:45
Conference pass
Using Big Data and Predictive Analytics to Determine Patients’ Profile/Risk in Oncology
Big Data in Oncology
David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca
Nov 811:45
Conference pass
Operational implementation of machine learning: Practical learnings and challenges
Analytics Platforms
Christophe Chabbert, Senior Scientist, Discovery In, Roche
Nov 811:45
Conference pass
FAIR in action – Accelerating Data Integration Using FAIR Approaches
Data Integration + FAIR
Martin Romacker, Data And Information Architect, Roche
Nov 811:45
Conference pass
In silico target identification for drug discovery
Bioinformatics +In Silico R&D
Philippe Sanseau, Head in Silico Target Biology, GSK
Nov 811:45
Conference pass
Biological sample registration and management: Integrating data workflows
Data Management, Storage and Architecture
Benjamin Li, Head of ITRDM Biological Sample Production & Manageme, Boehringer Ingelheim USA Corporation
Nov 811:45
Conference pass
Experiences of Digital Transformation within Pharmaceutical Sciences
Digital Transformation
Andy Phillips, Head of Digitisation, Pharmaceutical Sciences, AstraZeneca
Nov 811:45
Conference pass
Building a Network of RW Data in Rare Eosinophilic Diseases (EDs)
RWE
Heide Stirnadel-Farrant, TA Evidence Strategy Lead, Immunology, AstraZeneca
Nov 811:45
Conference pass
Miniaturized and automated transcriptomics of clinical rare cell samples
Single Cell Genomics
Stefan Kirsch, Head Innovative Molecular Technologies & Biomarker Discovery, Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Nov 811:45
Conference pass
Liquid biopsy: From discovery to clinical application
Liquid Biopsy
Catherine Alix Panabieres, Head of Circulating Rare Cells Laboratory, C.H.R.U. Montpellier
Nov 811:45
Conference pass
Novel approaches to structural genomic variation
Companion Diagnostics
James Broach, Director Of The Penn State Institute For Personalized Medicine, Penn State College of Medicine
Nov 811:45
Conference pass
Innovation in Genomic Medicine: Insight from Africa
Population Genomics
Delali Attiogbe Attipoe, Chief Operating Officer, 54gene
Colm O'Dushlaine, Vice President, Genomics and Data Science, 54gene
Nov 812:25
Conference pass
Digital Pathology Biomarkers for Immuno Oncology
Image Analysis
George Lee, Digital Pathology Informatics Lead and Data Scientist, Bristol Myers Squibb
Nov 812:25
Conference pass
Prediction of SAE Under Reporting in Ongoing Clinical Studies
AI in Drug Development
David Heard, Global Program Director, Novartis
Nov 812:25
Conference pass
AI for Medical Coding
NLP
Marion Legler, Head of Decision Science & Advanced Analytics for Medical Affairs, Pharmacovigilance & Regulatory Affairs, Bayer
Nov 812:25
Conference pass
Moving towards integrated DMTA cycles
Cheminformatics
Nicolas Bernsmeier, Senior Strategist, Bayer AG
Nov 812:25
Conference pass
Big Data to Improve Cancer Patient Experience
Big Data in Oncology
Mieke Van Hemelrijck, Professor in Cancer Epidemiology, King's College London
Nov 812:25
Conference pass
Federated analysis for biomarker discovery and beyond
Analytics Platforms
Mark Ibberson, Director, Vital-IT Competence Center in Bioinformatics, SIB Swiss Institute of Bioinformatics
Nov 812:25
Conference pass
Data integration at work: Use cases from Novartis
Data Integration + FAIR
Philippe Marc, Executive Director, Global Head Of Integrated Data Sciences, Novartis Institutes for Biomedical Research
Nov 812:25
Conference pass
Community-based team data science platform with U-BRITE
Bioinformatics +In Silico R&D
Jake Chen, Chief Bioinformatics Officer, University of Alabama at Birmingham
Nov 812:25
Conference pass
Handling Sensitive Patient Data Across Switzerland
Data Management, Storage and Architecture
Valerie Barbie, Director Clinical Bioinformatics, SIB Swiss Institute of Bioinformatics
Nov 812:25
Conference pass
How can digital technologies support patient care pathway optimisation
Digital Transformation
Marcos Gallego Llorente, Adjunct Professor, Research Director, Innovation, Sustainability and the Future of Healthcare, IE University
Nov 812:25
Conference pass
RWE in rare diseases, data networks and fit for purpose methods.
RWE
Daniel Rosenberg, Cross-Therapy Area Head, Global Epidemiology, Johnson & Johnson
Nov 812:25
Conference pass
Strategic use of single cell and tissue genomic applications in drug development
Single Cell Genomics
Tobias Bergauer, Deputy Head Genetics & Genomics, Roche
Nov 812:25
Conference pass
Chances and challenges for high volume liquid biopsy
Liquid Biopsy
Nikolas H Stoecklein, Professor Of Experimental Surgical Oncology General Visceral And Pediatric Surgery, University Hospital Duesseldorf
Nov 812:25
Conference pass
Phenome-wide association study of clonal haematopoiesis somatic mutations in 422,456 UK Biobank participants
Companion Diagnostics
Jonathan Mitchell, Genome Analyst, Astra Zeneca
Nov 812:25
Conference pass
Advances in genomic medicine: Enabling new capabilities for personalised care
Population Genomics
Scott Chandler, Global Head, Personalized Health Care (PHC) Safety, F. Hoffmann - La Roche
Nov 813:05
Conference pass
Empowering pathologists with AI authoring
Image Analysis
Volker Bruns, Group Manager Medical Image Processing, Fraunhofer IIS
Nov 813:05
Conference pass
Trustworthy AI for pharmaceutical research
AI in Drug Development
Tao Xu, Senior Data Scientist, Roche
Nov 813:05
Conference pass
Using NLP to improve patient outcomes
NLP
Elif Ozkirimli, Head of Data Science and Advanced Analytics - Pharma International Data and Analytics Chapter, Roche
Nov 813:05
Conference pass
Developing AI tools that are accessible to chemists
Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry (Data Science), Boehringer Ingelheim Pharma GmbH & Co. KG
Nov 813:05
Conference pass
Using Big Data across the NHS and healthcare providers to improve patient outcomes in cancer
Big Data in Oncology
Steven Hardy, Head of Molecular Diagnostics, National Disease Registration Service, Data Services Directorate, NHS digital
Nov 813:05
Conference pass
Diagnosing COVID-19 through audio AI
Analytics Platforms
Bjorn Schuller, Professor of AI & Chair of Embedded Intelligence for Health Care and Wellbeing, Imperial College London
Nov 813:05
Conference pass
Leveraging EHR data across multiple hospitals to support integrated research platforms
Data Integration + FAIR
Nadir Ammour, Global Lead, External Engagement for Clinical Innovation Office, Sanofi
Nov 813:05
Conference pass
Connecting Clinical Trials to Real World Data
Data Management, Storage and Architecture
Gian Prakash, Director, Data Engineering, AbbVie
Nov 813:05
Conference pass
Companion Digital Products to Create a Digital Ecosystem for Patients: Treating the Holistic Person
Digital Transformation
Caoimhe Vallely-Gilroy, Head of Digital Health & Therapeutics, Merck Healthcare KGaA
Nov 813:05
Conference pass
Patient held EHR: Empowering citizens to track their health and ensuring consent based access to RWD
RWE
Dominik Geller, Founder and Advisor, Hygiaso AG
Nov 813:05
Conference pass
Cardiac single cell analysis and novel therapies
Single Cell Genomics
Ralph Knoell, Chief Scientist, AstraZeneca
Nov 813:05
Conference pass
Regulatory Considerations for CDx for Medicinal Products in Oncology and Cell and Gene Therapy
Companion Diagnostics
Philipp Schatz, Global Regulatory Strategist – IVD, BAYER
Nov 813:05
Conference pass
Achieving greater genomic diversity in America: More diversity more learning
Population Genomics
Chris Lunt, Chief Technical Officer, National Institutes of Health, All of Us Program
Nov 814:25
Conference pass
Chair remarks
Image Analysis
Elton Rexhepaj, Director, Data Science, AIDA (Artificial Intelligence and Deep Analytics R&D department), Sanofi
Nov 814:25
Conference pass
Chair remarks
AI in Drug Development
Bonnie Kruft, Head of Research Data & Analytics, AstraZeneca
Nov 814:25
Conference pass
Chair remarks
Cheminformatics
Christian Kramer, Head of Computer-Aided Drug Design, Roche
Nov 814:25
Conference pass
Chair remarks
Big Data in Oncology
Autri Dutta, Vice President, Lifecycle Leader - Informatics, Roche Diagnostics
Nov 814:25
Conference pass
Chair remarks
Analytics Platforms
Thil Batuwangala, Head of Biopharm Discovery Data Strategy, GSK
Nov 814:25
Conference pass
Chair remarks
Data Integration + FAIR
George Papadatos, Global Head Data Strategy and Assets, Syngenta
Nov 814:25
Conference pass
Chair remarks
Data Management, Storage and Architecture
Andreas Steinbacher, Lead Discovery Informatics Data Management, Roche
Nov 814:25
Conference pass
Chair remarks
Digital Transformation
Christoph Huels, Internal Entrepreneur In Action, Merck Healthcare KGaA
Nov 814:25
Conference pass
Chair remarks
RWE
Tifani Mccann, Vice President, Chief Data and Analytics Officer, Otsuka Pharmaceutical
Nov 814:25
Conference pass
Chair remarks
Single Cell Genomics
Vivek Das, Senior Research Scientist, Novo Nordisk
Nov 814:25
Conference pass
Chair remarks
Liquid Biopsy
Sam Hanash, Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center
Nov 814:25
Conference pass
Chair remarks
Companion Diagnostics
Carolina Haefliger, Head Translational Medicine, Debiopharm International SA
Nov 814:30
Conference pass
Image analysis for liver disease
Image Analysis
Benjamín Gutierrez Becker, R&D Imaging Data Analysis Expert, Roche
Nov 814:30
Conference pass
NLP extraction of entities from long text forms in a complex world
NLP
Fausto Artico, Global R&D Tech Head of Innovation and Data Science, GSK
Nov 814:30
Conference pass
Platforms For Automated Designs
Cheminformatics
Stephen Pickett, Scientific Director, GSK
Nov 814:30
Conference pass
Scaling-up analytics platforms to serve the heterogenous needs of a pharma company
Analytics Platforms
Justin Lecher, Manager High Performance & Scientific Computing, AstraZeneca
Nov 814:30
Conference pass
Building Knowledge Graphs Across Clinical Data
Data Integration + FAIR
Ben Gardner, Product Owner for Data Mesh and Semantic Infrastructure, AstraZeneca
Nov 814:30
Conference pass
Functional genomics for novel target discovery in cancer: Valuable learnings from the CRUK and AstraZeneca partnership
Bioinformatics +In Silico R&D
Ultan McDermott, Chief Scientist, Oncology, AstraZeneca
Nov 814:30
Conference pass
Cells 2.0
Data Management, Storage and Architecture
Anke Eisenmann, Principal Scientist, Hoffmann-La Roche
Nov 814:30
Conference pass
How to Improve Patients Outcome With Digital Health
Digital Transformation
David Herzig, Senior Scientist - Research Informatics, Roche Pharmaceuticals
Nov 814:30
Conference pass
Establishing a platform for evidence generation: Achieving greater automation to increase speed, cost-savings and the quality of evidence
RWE
Alexander Büsser, Global RWE Analytics Lead, Idorsia
Nov 814:30
Conference pass
Sparsely Connected Autoencoders: a multi-purpose tool for single cell OMICs analysis
Single Cell Genomics
Raffaele Calogero, Professor, University of Torino
Nov 814:30
Conference pass
Exploring the challenges of early cancer detection
Liquid Biopsy
Klaus Pantel, Chairman and Professor of Medicine, Institute for Tumor Biology University of Hamburg
Nov 814:30
Conference pass
Companion diagnostics for homologous recombination repair in oncology
Companion Diagnostics
Timothy Schatz, Medical Director, Biomarkers and Diagnostics, Astra Zeneca
Nov 814:30
Conference pass
The effects of climate change on modern human populations visualised by population genomics
Population Genomics
Stephan Schuster, Professor, Nangyang Technological University
Nov 815:10
Conference pass
Multi-model imaging and genomic machine learning for cancer
Image Analysis
Parker Moss, Chief Commercial & Partnership Officer, Genomics England
Nov 815:10
Conference pass
AI for target discovery: Using interpretable AI to discover and de-risk novel targets
AI in Drug Development
Neel Madhukar, Chief Executive Officer, OneThree Biotech
Nov 815:10
Conference pass
Strengthening transformer-based deep neural networks for clinical and operational use
NLP
Edmon Begoli, AI Systems R&D Section Head and Distinguished Scientist, Oak Ridge National Laboratory (ORNL)
Nov 815:10
Conference pass
DNA Encoded Library Data Analytics
Cheminformatics
Sergio Cuesta, Senior Data Scientist in Bioinformatics,, Astra Zeneca
Nov 815:10
Conference pass
Battling data fragmentation in Oncology drug development: Advancing competitive intelligence to drive strategy
Big Data in Oncology
Subha Madhavan, Head of Data Science, Oncology R&D, AstraZeneca
Nov 815:10
Conference pass
Improving patient outcomes through analytical tools in the real world
Analytics Platforms
Matthias Antonin, Innovation Lead Medical Practice, Neuroscience, Roche
Nov 815:10
Conference pass
Connecting the dots within the R&D data landscape: Building a solid data backbone
Data Integration + FAIR
Markus Hartmann, Head of Data Value Office, Merck
Nov 815:10
Conference pass
Exploring the impact of the virtual patient on R&D
Bioinformatics +In Silico R&D
Thierry Lavé, Head Project Leaders and M&S, Roche
Nov 815:10
Conference pass
Management of internal and external data sets to improve access, efficiency and collaboration across an organisation
Data Management, Storage and Architecture
Yuliya Nigmatullina, Biomedical Data Sourcing Lead, UCB
Nov 815:10
Conference pass
Ensuring the right digital skillset and technologies in an ever-changing pharma environment
Digital Transformation
Michelangelo Canzoneri, Global Head of Digital and Data, Healthcare, Merck Healthcare KGaA
Nov 815:10
Conference pass
Merging Clinical Trial & Real-World Data: A Tokenization Framework to Manage Technology, Legal, Regulatory & Privacy Concerns
RWE
Aman Thukral, Head of Digital Operations and Clinical Systems, AbbVie
Nov 815:10
Conference pass
Integrated Multi-Omics Reveal Polycomb Repressive Complex 2 Restricts Human Trophoblast Induction
Single Cell Genomics
Hendrik Marks, Assistant Professor and Group Leader, Radboud University Hospital
Nov 815:10
Conference pass
Developing novel technologies for enriching mutant sequences in liquid biopsy of cancer
Liquid Biopsy
Mike Makrigiorgos, Professor For Department Of Radiation Oncology, Dana Farber and Harvard Medical School
Nov 815:10
Conference pass
Theranostics in haematological malignancies
Companion Diagnostics
Stefan Habringer, Physician, Charité - Universitätsmedizin Berlin
Nov 815:10
Conference pass
Therapeutic gene editing: Using genomics data to target genetic diseases
Population Genomics
Grzegorz Sienski, Principal Scientist, AstraZeneca
Nov 815:50
Conference pass
Federated And Image Data for Improving Activity Models
Image Analysis
Hugo Ceulemans, Scientific Director, Discovery Data Sciences, Janssen Pharmaceutical NV
Nov 815:50
Conference pass
AI and structural biology for molecular glue degraders
AI in Drug Development
John Castle, Chief Data Science Officer, Monte Rosa Therapeutics
Nov 815:50
Conference pass
Automated literature reviews
NLP
Luisa Queiros, Global Access Evidence Lead, Roche
Nov 815:50
Conference pass
AI in medicinal chemistry: Challenges and opportunities
Cheminformatics
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry, Biogen
Nov 815:50
Conference pass
Harnessing Real World Evidence for the development of novel cancer therapies
Big Data in Oncology
Tine Lewi, Scientific Director - Patient Data for Research, Clinical Innovation, Janssen
Nov 815:50
Conference pass
Use of advanced analytics to predict risk: Relying on existing biomarkers to advance treatment
Analytics Platforms
Michael Zaiac, Head of Medical Affairs Oncology Region Europe, Novartis
Nov 815:50
Conference pass
AstraZeneca's 2 Million Genomes Initiative and the relevance of FAIR Data Principles in Pharmaceutical R & D
Data Integration + FAIR
Chuang Kee Ong, Associate Director, Lead Information Architecture, (Early Science), AstraZeneca
Nov 815:50
Conference pass
Computational and wet methods to approach genomic disregulation and causal events
Bioinformatics +In Silico R&D
Trevor Howe, Head, Translational Genomics, Johnson & Johnson
Nov 815:50
Conference pass
Re-imagine High-Quality Data Production: The Novartis journey to build a Lean Digital Core
Data Management, Storage and Architecture
Johannes Galatsanos, Head of Data, Lean Digital Core, ERP Transformation, Novartis
Nov 815:50
Conference pass
Application of digital tools for Clinical Microbiology – a rocky road
Digital Transformation
Adrian Egli, Prof. Adrian Egli, Director Institute of Medical Microbiology, University of Zurich
Nov 815:50
Conference pass
Share without Sharing: Privacy-Preserving, Secure Federated Analytics
RWE
Jean-Pierre Hubaux, Full Professor, Ecole Polytechnique Fédérale de Lausanne, EPFL
Nov 815:50
Conference pass
Functional multi-omics in precision medicine
Single Cell Genomics
Marianna Kruithof-De Julio, Head of Urology Research Laboratory and Clinical Research and Director of Organoid Core, Universitat Bern
Nov 815:50
Conference pass
The role of biobanking in supporting liquid biopsy research and clinical application
Liquid Biopsy
Jens K Habermann, Director General, BBMRI-ERIC
Nov 815:50
Conference pass
Same day tumor DNA methylation profiling: the Basel approach to diagnostic precision medicine
Companion Diagnostics
Stephan Frank, Head Neuropathology, University Hospital Basel
Nov 815:50
Conference pass
Latest update on the Qatar Genome Project (QGP): Moving from bench to bedside
Population Genomics
Said Ismail, Director Of Qatar Genome Programme, Qatar Foundation
Nov 816:40
Conference pass
Chair remarks
AI in Drug Development
Bulent Kızıltan, Head, Causal & Predictive Analytics, Novartis
Nov 816:40
Conference pass
Chair remarks
Big Data in Oncology
Sonia Houston Pichardo, Business Lead of MyStudyWindow, Boehringer Ingelheim
Nov 816:40
Conference pass
Chair remarks
Analytics Platforms
Igor Rudychev, Vice President, Enterprise Analytics, Horizon Therapeutics
Nov 816:40
Conference pass
Chair remarks
Data Integration + FAIR
David Drake, Drug Discovery IT Capability Lead, AstraZeneca
Nov 816:40
Conference pass
Chair remarks
Digital Transformation
Uli Broedl, Head of Global Clinical Development and Operations, Boehringer-Ingelheim
Nov 816:40
Conference pass
Chair remarks
RWE
François-Xavier chalet, Health Economist Specialist, Idorsia
Nov 816:40
Conference pass
Chair remarks
Population Genomics
Ailsa Craig, Physician, Lausanne University Hospital
Nov 816:45
Conference pass
Digital pathology to predict genetic mutation
Image Analysis
Adrien Rousset, Head of Augmented Diagnostics & Patient Identification, Amgen
Nov 816:45
Conference pass
AI in drug Discovery: Recent Examples
AI in Drug Development
Rolf Jautelat, VP Strategy & Business Transformation, Bayer
Nov 816:45
Conference pass
Scaling natural language processing for pharmaceutical R&D and medical safety
NLP
Srikanth Ramakrishnan, Director, Pharmaceutical R&D, Intelligent Automation & Analytics, Johnson & Johnson
Nov 816:45
Conference pass
AI for optimised drug discovery
Cheminformatics
David Palmer, Senior Lecturer, University of Strathclyde Glasgow
Nov 816:45
Conference pass
Information extraction for oncological purposes
Big Data in Oncology
Enrico Santus, Senior Lead Data Scientist, (Director, AI & ML), BAYER
Nov 816:45
Conference pass
What is decision intelligence: Moving from analytics to outcomes
Analytics Platforms
Curtis Newkirk, Informatics Head - Data Analytics, Pharma Commercial, Medical Affairs, Global Access, & Pharma Partnering, Roche
Nov 816:45
Conference pass
Creation of a FAIR in-vivo data sharing platform
Data Integration + FAIR
Olivier Roche, Global Data Quality Coordinator, Biology Workflow Team Leader, Roche
Nov 816:45
Conference pass
Data science and bioinformatics for target identification
Bioinformatics +In Silico R&D
Florian Nigsch, Associate Director Data Science, Novartis Institutes for Biomedical Research
Nov 816:45
Conference pass
BioMedIT: Switzerland’s secure IT environment for sensitive data.
Data Management, Storage and Architecture
Katrin Crameri, Head Personalised Health Informatics, SIB Swiss Institute of Bioinformatics
Nov 816:45
Conference pass
Breaking down barriers to deliver digital transformation successfully
Digital Transformation
Sibel Guerler, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb
Nov 816:45
Conference pass
RWE burden of illness study in France
RWE
Darren Talbot, Global Value & Access, Senior Director, Idorsia
Nov 816:45
Conference pass
Fast and highly sensitive full-length single-cell RNA-sequencing using FLASH-seq
Single Cell Genomics
Simone Picelli, Platform Leader Single - Cell Genomics, Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Nov 816:45
Conference pass
Donor-derived cell-free DNA in transplant diagnostics
Liquid Biopsy
Michael Oellerich, Professor, University Medical Center Göttingen, George-August-University Göttingen, Germany
Nov 816:45
Conference pass
Donor-derived cell-free DNA in transplant diagnostics
Liquid Biopsy
Michael Oellerich, Professor, University Medical Center Göttingen, George-August-University Göttingen, Germany
Nov 816:45
Conference pass
Biomarkers guiding precision medicine in Psoriatic Arthritis based on genomics and proteomics analysis of clinical trials
Companion Diagnostics
Richard Siegel, Global Head, Translational Medicine, Co-Head, integrated Translational Research, Autoimmunity, Transplantation and Inflammation, Novartis
Nov 816:45
Conference pass
Mirroring population health models in vivo with CRISPR technology
Population Genomics
Danilo Maddalo, Group Leader - Translational Oncology, Genentech
Nov 817:05
Conference pass
Panel Discussion: How to harness RWE to shape clinical trial design?
RWE
Dominik Hartl, Chief Medical Officer (CMO), Quell Therapeutics
Khaled Sarsour, Vice President of Real-World Evidence (RWE) Analytics and Insights, Janssen R&D
Basker Gummadi, Head of Digital Health, Gilead Sciences
Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche
Claus Andersen, Director Data Science, Galapagos
Paul Petraro, Executive Director, Global Head Real World Evidence Analytic (RWE) Center of Excellence, Boehringer Ingelheim
Melvin Olson, Global Head Integrated Evidence Strategy and Innovation, Novartis
Nov 817:25
Conference pass
Panel Discussion: Addressing the gap between theory and practice for AI in pharma
AI in Drug Development
Paul Agapow, Director, GSK
Victoria Gamerman, Global Head of Data Governance and Insights, Boehringer Ingelheim
Alain Bindels, Innovation & Technology Leader, Roche
Han Chang, Senior Director, Head of Late Stage Oncology, Translational Bioinformatics, Bristol-Myers Squibb
Bulent Kızıltan, Head, Causal & Predictive Analytics, Novartis
Nov 817:25
Conference pass
Panel Discussion
Big Data in Oncology
Sonia Houston Pichardo, Business Lead of MyStudyWindow, Boehringer Ingelheim
Martin Urban, Data Governance Manager, Boehringer-Ingelheim
Nov 817:25
Conference pass
Panel Discussion: How can we improve the standard of EMR data across the globe and analytics capabilities to help patients?
Analytics Platforms
Igor Rudychev, Vice President, Enterprise Analytics, Horizon Therapeutics
Luis Prieto Rodriguez, Global Real-World Evidence Director, Novartis
Marco Roos, Associate Professor and Leader of the Biosemantics Research, Leiden University Medical Center
William Paiva, Managing Partner, Oklahoma Life Science Fund
Nov 817:25
Conference pass
Panel Discussion: Enabling access to health data while protecting privacy
Data Integration + FAIR
Nicola Orlandi, Executive Director Compliance, Head of Global Data Privacy, Bausch Health
Sidharth Jain, Head of Global Development Data Science, Janssen R&D
Tanja Stamm, Head of Section for Outcomes Research, Medical University of Vienna
Santha Ramakrishnan, Global Data Governance Lead, Sanofi
Rosie Richards, Head of European Digital Research, NHS Confederation
Sarion Bowers, Head of Policy, Wellcome Sanger Institute
Nov 817:25
Conference pass
Panel Discussion: Leveraging new technologies to support bioinformatics in drug discovery
Bioinformatics +In Silico R&D
Asli Ismihan Ozen, Head of Bioinformatics & Data Mining, novo nordisk
Mohamed-Ramzi Temanni, Scientific Director, Head of France AI/Genomics, Computational Science, Janssen
Magdalena Zwierzyna, Scientific Director (Data Science); Vx R&D, Vaccine Projects and Digital Sciences, GSK
Graham Ball, Professor of Bioinformatics, Nottingham Trent University
Nov 817:25
Conference pass
Panel Discussion: Going beyond the norm - Perspectives & innovation in research and digital capabilities across the healthcare ecosystem
Digital Transformation
Sheetal Chawla, Head of Analytics Strategy & Transformation, Global Product Strategy, Roche
Arne Müller, AD & Senior Principal Data Scientist in Clinical Digital Endpoints, Novartis
Julie Huxley-Jones, VP of Research Solutions, GlaxoSmithKline
Caroline Schmidt, Global Head of Enterprise Digital, Takeda
Paolo Piraino, Innovation Manager (STM), Data Science and Analytics, Bayer
Lili Peng, Head External Innovation Data Sciences, Biogen
Lada Leyens, Global Regulatory lead - Clinical Trial Innovation and Digital Health – PHC, Roche
Nov 817:25
Conference pass
Panel Discussion: Large scale genome programs – update on global genomics efforts and representation of diverse genomes
Population Genomics
Delali Attiogbe Attipoe, Chief Operating Officer, 54gene
Sàndor Szalma, Global Head, Computational Biology, Takeda
Ciara Vangjeli, Genetics Lead Director, UCB
Said Ismail, Director Of Qatar Genome Programme, Qatar Foundation
Create your personal agenda –check the favourite icon
Nov 98:55
Conference pass
Chair remarks
Keynotes
Alexander Krupp, Digital Lead Research, Development, Medical and Pharmacovigilance, Bayer
Nov 98:55
Conference pass
Chair remarks
Plenary - Genomics Live
Marc Sultan, Head Genetics & Genomics, Pharmaceutical Research and Early Development, Roche
Nov 99:00
Conference pass
data42: Accelerating insights from connected data to achieve greater value for patients
Keynotes
Peter Speyer, Head of Customer Success, data42, Novartis
Nov 99:00
Conference pass
How genomic data is helping transform lives and mainstream genomics across the NHS in England
Plenary - Genomics Live
Sue Hill, Chief Scientific Officer, NHS England
Nov 99:20
Conference pass
Drug Targets from large cohorts with WGS, longitudinal clinical data, and tissue single nucleus sequencing
Plenary - Genomics Live
Jeffrey Gulcher, Chief Scientific Officer, Genuity Science
Nov 99:40
Conference pass
Building the future of computational pathology and AI at the Mayo Clinic
Plenary - Genomics Live
Jason Hipp, Chair, Computational Pathology & AI, Mayo Clinic
Nov 911:40
Conference pass
Chair remarks
AI in Drug Development
Scott Oloff, SVP of Data & Analytics, pRED, Roche
Nov 911:40
Conference pass
Chair remarks
Big Data in Oncology
Julie Woodland, Head of Strategic Planning and Business Implementation, Astra Zeneca UK Ltd
Nov 911:40
Conference pass
Chair remarks
Analytics Platforms
Ramin Daron, Head, Applied Data Sciences and Learning, Data Sciences Institute, Research and Development, Takeda
Nov 911:40
Conference pass
Chair remarks
Data Integration + FAIR
Derek Marren, Principal IT Business Manager, Pre-clinical Capability, AstraZeneca
Nov 911:40
Conference pass
Chair remarks
Data Management, Storage and Architecture
Ralph Haffner, Head of Information Products and Data Sciences, Novartis Institutes for Biomedical Research
Nov 911:40
Conference pass
Chair remarks
Digital Transformation
Lucas Scherdel, Director, DayOne
Nov 911:40
Conference pass
Chair remarks
RWE
Dorothee Bartels, Global Head RWE, UCB
Nov 911:40
Conference pass
Chair remarks
Companion Diagnostics
Jason Hipp, Chair, Computational Pathology & AI, Mayo Clinic
Nov 911:45
Conference pass
Using imaging AI to optimise clinical trials
Image Analysis
Alexander Goehler, Executive Director, Precision Medicine, Imaging and AI Lead, Novartis Institutes for Biomedical Research
Nov 911:45
Conference pass
Spatial Biology Biomarkers for Targeted Therapies
AI in Drug Development
Anna Pokorska-Bocci, Associate Principal Scientist, Personalised Medicine, Debiopharm
Nov 911:45
Conference pass
Complex terms for the medical domain.
NLP
Lonneke van der Plas, Group Leader, Idiap Research Institute
Nov 911:45
Conference pass
Artificial Intelligence in Drug Discovery 2022 - Aspects of Translation, Validation, and Where We are on the Hype Cycle
Cheminformatics
Andreas Bender, Reader Of Molecular Informatics, University Of Cambridge
Nov 911:45
Conference pass
Collaborative R&D
Analytics Platforms
Gabriel Eichler, VP, Head of Data, Novartis
Nov 911:45
Conference pass
Data Catalogues
Data Integration + FAIR
Etzard Stolte, Global Head Of Knowledge Management Ptd, Roche
Nov 911:45
Conference pass
Development of a synthetic lethality framework to predict biomarkers for precision therapies
Bioinformatics +In Silico R&D
Anna Maria Lara Coenen Stass, Principal Scientist Translational Medicine, Oncology Bioinformatics, Merck Group
Nov 911:45
Conference pass
Improving R&D Productivity with Modular Knowledge and Decision-Making Platform
Digital Transformation
Tomas Kvedaravicius, Senior Director, Head of Data Collaboration & Intelligence, R&D Tech, GSK
Nov 911:45
Conference pass
How RWD can help Carers in Reducing Variability in Cancer Care and Outcomes
RWE
Sanjoy Paul, Real World Evidence Leader – Oncology, AstraZeneca
Nov 911:45
Conference pass
Integration of multi-omics in animal models and human disease
Single Cell Genomics
Zsolt Illes, Professor, Odense University Hospital
Nov 911:45
Conference pass
Transformation in Cancer Care at Roche
Liquid Biopsy
Jan Hoffmann, Precision Medicine Partner, Roche
Nov 911:45
Conference pass
Using AI and machine learning to discover de novo biomarkers of drug response and biological drug targets
Companion Diagnostics
Graham Ball, Professor of Bioinformatics, Nottingham Trent University
Nov 911:45
Conference pass
Exploring pain genetics in rare diseases
Rare Diseases & NGS
Achim Kless, Pain Genetics Lead, Discovery Neuroscience Research, Neuroscience Genetics, Eli Lilly and Company
Nov 912:25
Conference pass
Practical application of AI for clinical imaging data
Image Analysis
Joerg Degen, Head Early Development Informatics, Roche
Nov 912:25
Conference pass
New cheminformatics challenges in the evolving world of drug discovery
Cheminformatics
Ioana Oprisiu, Cheminformatics Data Scientist, AstraZeneca
Nov 912:25
Conference pass
A data driven approach to external innovation at a Biotech company
Analytics Platforms
Lili Peng, Head External Innovation Data Sciences, Biogen
Nov 912:25
Conference pass
Implementing FAIR in early research
Data Integration + FAIR
Saritha Kuriakose, Director - Data Integration & Ontologies, novo nordisk
Nov 912:25
Conference pass
Why Switzerland is becoming a ‘Digital Health Nation’?
Digital Transformation
Ursula Costa, Lead Digital Health Nation Innovation Booster, DayOne
Nov 912:25
Conference pass
Prognostic biomarker Identification in Huntington’s disease with RWD machine learning modelling
RWE
Naghmeh Ghazaleh, Senior Data scientist, F. Hoffmann-La Roche
Nov 912:25
Conference pass
Single-cell RNA-seq in bacteria
Single Cell Genomics
Christina Homberger, Scientist NGS, Julius Maximilians Universitat Wurzburg
Nov 912:25
Conference pass
Towards Molecular Digital Biosensor Based Remote Clinical Trial Aided Medical Technology Technology Solutions
Liquid Biopsy
Seppo Vainio, Vice Director, GeneCellNano Academy Flagship
Nov 912:25
Conference pass
Logistical challenges of integrating molecular testing into daily practice of gynaecologic pathology
Companion Diagnostics
Bojana Djordjevic, Staff Pathologist, Gynaecologic Pathology Section Lead, Sunnybrook Health Sciences Centre
Nov 912:25
Conference pass
Genomics England: Exploring the value of sequencing all new-born children
Rare Diseases & NGS
Richard Scott, Chief Medical Officer, Genomics England
Nov 912:45
Conference pass
Knowledge Graph for Drug discovery
AI in Drug Development
Thierry Dorval, Head of Data Sciences & Data Management, Servier
Nov 913:05
Conference pass
Using computer vision to support clinical assessment and beyond
Image Analysis
John Chan, Head, ShinrAI Center for Artificial Intelligence/ Machine Learning, Takeda
Nov 913:05
Conference pass
Augmenting Drug Design Using Data and AI
AI in Drug Development
Prakash Rathi, Engineering Lead, Augmented Drug Design, AstraZeneca
Nov 913:05
Conference pass
High-throughput screening for the discovery of new bacterial spore germinants
Cheminformatics
Paulo Alexandrino, Doctoral Researcher, Max-Planck Institute for Terrestrial Microbiology
Nov 913:05
Conference pass
Streamlining the analytical life cycle process: From idea to product
Analytics Platforms
Frank Block, Head of IT Data Science, Roche Diagnostics International Ltd
Nov 913:05
Conference pass
Five reasons why bioinformatics & AI is transforming vaccines discovery and development
Bioinformatics +In Silico R&D
Magdalena Zwierzyna, Scientific Director (Data Science); Vx R&D, Vaccine Projects and Digital Sciences, GSK
Nov 913:05
Conference pass
Knowledge graphs in healthcare research
Data Management, Storage and Architecture
Alexander Jarasch, Head of Data and Knowledge Management, German Center for Diabetes Research (DZD)
Nov 913:05
Conference pass
Enabling meaningful collaboration between data scientists and clinicians by developing visualising tools
Digital Transformation
Andrea Derix, Sr. Global Program Head, Bayer
Nov 913:05
Conference pass
Leveraging Real World Data and AI for Oncology Patient Progression Prediction
RWE
Helena Yin Koeppl, Vice President, Global Head Of Data Science And Advanced Analytics, Bayer Pharmaceuticals
Nov 913:05
Conference pass
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
Single Cell Genomics
Zhongyi Wang, postdoc, Novartis
Nov 913:05
Conference pass
Development and application of molecular assays for CTC’s and CtDNA
Liquid Biopsy
Evi Lianidou, Professor Of Analytical Chemistry And Clinical Chemistry, University of Athens
Nov 913:05
Conference pass
Metagenomic studies to detect viral and bacterial/fungal contaminants in samples to be used for human intervention
Companion Diagnostics
Dawid Walas, Global Head of Omics R&D, Merck Group
Nov 913:05
Conference pass
Whole genome sequencing for rare diseases and exploratory analysis for clinical trials
Rare Diseases & NGS
Sandra Smieszek, Head Of Genetics, Vanda Pharmaceuticals Inc
Nov 914:25
Conference pass
Chair remarks
AI in Drug Development
Daniel Joseph Price, Head of Excipent Solid Applicatin, Merck Group
Nov 914:25
Conference pass
Chair remarks
Big Data in Oncology
Basker Gummadi, Head of Digital Health, Gilead Sciences
Nov 914:25
Conference pass
Chair remarks
Analytics Platforms
Omar Khawaja, Head of BI & Analytics, Roche Diagnostics
Nov 914:25
Conference pass
Chair remarks
Data Integration + FAIR
Andrew Robertson, VP and Head of Global Regulatory Policy and Digital Innovation, Global Regulatory Affairs, Takeda
Nov 914:25
Conference pass
Chair remarks
Digital Transformation
Yves Fomekong-Nanfack, Head of Digital Biologics Platform Operations, Sanofi
Nov 914:25
Conference pass
Chair remarks
RWE
Thirupathi Pattipaka, AD, Data Science, Novartis
Nov 914:30
Conference pass
Synthesis design system landscape for computational chemistry
Image Analysis
Jan Baumann, Principal Scientist, Research and Lab Informatics, Merck
Veit Ulshöfer, Senior Director, Global Head of Research Informatics, Merck Healthcare KGaA
Nov 914:30
Conference pass
Upscaling AI Powered Drug Discovery – Lessons Learnt From The Patrimony Computing Platform
AI in Drug Development
Philippe Moingeon, Head of therapeutic area immuno-inflammation. Application of AI to drug development, Servier
Nov 914:30
Conference pass
Use of cheminformatics for AstraZeneca medicinal chemistry
Cheminformatics
Werngard Czechtizky, Executive Director Head Medicinal Chemistry Respiratory and Immunology, and Chair of AZ Global Chemistry Leadership, AstraZeneca
Nov 914:30
Conference pass
Building back better: Harnessing the successes during COVID to improve analytical capabilities across health and social care
Analytics Platforms
Adrian Jonas, Chief Analyst for the North West Region, NHS England & NHS Improvement
Nov 914:30
Conference pass
FAIR data integration in federated medical settings
Data Integration + FAIR
Petr Holub, Senior IT/Data Protection Manager, BBMRI-ERIC
Nov 914:30
Conference pass
Using genomics to drive decision-making in drug development
Bioinformatics +In Silico R&D
Joanna Betts, Head of Translational Omics, Computational Biology, GSK
Nov 914:30
Conference pass
Qualifications based access data: Innovative model for data governance
Data Management, Storage and Architecture
David Hurry, Head, Data Services and Content Delivery, Takeda Research & Development Center, Inc.
Nov 914:30
Conference pass
New ways of working to improve R&D and collaboration of digital product teams
Digital Transformation
Jobst Loeffler, Product Owner, Digital Transformation & IT Pharma, Bayer
Nov 914:30
Conference pass
Bioinformatics and Target Discovery in times of high-throughput multi-modal technologies.
Single Cell Genomics
Vivek Das, Senior Research Scientist, Novo Nordisk
Nov 914:30
Conference pass
Genetics in Drug Development
Companion Diagnostics
Dipender Gill, Advanced Research Fellow, Imperial College London
Nov 914:30
Conference pass
AstraZeneca’s Genomics initiative – insights into heart failure
Rare Diseases & NGS
Dirk Paul, CVRM Genomics Therapy Area, AstraZeneca
Nov 914:50
Conference pass
DNA methylome sequencing – insight into epigenetics of non-small-cell lung cancer
Rare Diseases & NGS
Miljana Tanic, Senior Research Associate – Principal Investigator, Institute for Oncology and Radiology of Serbia
Nov 915:10
Conference pass
Decoding neurodegenerative disorders combining AI and high content imaging
Image Analysis
Raphaëlle Luisier, Group Leader, Idiap Research Institute
Nov 915:10
Conference pass
Computational chemistry and data science for formulation development
AI in Drug Development
David Luedeker, Principal Scientist, Merck Healthcare KGaA
Nov 915:10
Conference pass
Impact of non-additivity for ML&AI in drug discovery
Cheminformatics
Christian Tyrchan, Team leader Computational Chemistry, AstraZeneca
Nov 915:10
Conference pass
Conducting discovery analysis in the Genomics England trusted research environment: The case of COVID-19 critical illness
Analytics Platforms
Athanasios Kousathanas, Principal Genomics Data Scientist, Genomics England
Nov 915:10
Conference pass
Drug discovery in the bacterial space with AI supported semantic technologies
Data Integration + FAIR
Sebastian Scharf, Senior Data Scientist, Roche
Nov 915:10
Conference pass
Harnessing genomics to identify novel therapeutic targets
Bioinformatics +In Silico R&D
Aimee Deaton, Associate Director, Human Genetics, Alnylam Pharmaceuticals
Nov 915:10
Conference pass
FAIR data hub for analytical chemistry data
Data Management, Storage and Architecture
Arndt Finkelmann, RnD IT Operations Lead, Syngenta Crop Protection AG
Nov 915:10
Conference pass
Digital Remote Monitoring in Ophthalmology
Digital Transformation
Leslie Anne Fendt, Digital Health Product Leader, Roche
Nov 915:10
Conference pass
Digital Remote Monitoring in Ophthalmology
Digital Transformation
Leslie Anne Fendt, Digital Health Product Leader, Roche
Nov 915:10
Conference pass
Use of Real world data for Safety
RWE
Jost Leemhuis, Head Of Safety Science, Roche
Nov 915:10
Conference pass
Immuno Precision Medicine for Cardiovascular Disease Patients
Single Cell Genomics
Stefan Bekiranov, Associate Professor, University of Virginia School of Medicine
Nov 915:10
Conference pass
The wide world of liquid biopsy platforms for cancer early detection
Liquid Biopsy
Sam Hanash, Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center
Nov 915:10
Conference pass
Recommending the International Use of a Low-Cost, Sensitive, HIV-1 Total HIV-1 Nucleic Acid Quantitative Assay with Broad Subtype Specificity
Companion Diagnostics
Catherine Kibirige, Research Associate, Imperiai College London
Nov 915:10
Conference pass
Benefit of Basket Trials with rare disease patients of shared molecular etiology
Rare Diseases & NGS
Christina Waters, Chief Executive Officer, RARE Science
Nov 915:50
Conference pass
Use of machine learning in an image analysis pipeline to assess Covid Antibody Status in home tests.
Image Analysis
Anil Bharath, Founder, Imperial College London
Nov 915:50
Conference pass
Not Just Deep Fakes: Applications of Visual Generative AI Models in Pharma Manufacturing
AI in Drug Development
Guglielmo Iozzia, Associate Director - Business Tech Analysis, Machine Learning and AI, MSD
Nov 915:50
Conference pass
Fragment based lead discovery at protein hotspots with smart libraries
Cheminformatics
György Keseru, Research Centre For Natural Sciences Of HAS
Nov 915:50
Conference pass
Journey of creating a modern self-service data & analytics platform
Analytics Platforms
Paul Rankin, Head of Data Management Platforms, Roche Diagnostics
Nov 915:50
Conference pass
FAIRness evaluation: Commercial application and opportunities
Data Integration + FAIR
Michel Dumontier, Distinguished Professor Of Data Sciences And Co-Founder Of The Fair Data Principles, Universiteit Maastricht
Nov 915:50
Conference pass
Towards the identification of biomarkers of NASH/NAFLD disease progression
Bioinformatics +In Silico R&D
vincent mikol, Precision Medicine Head, Rare diseases & neuro, sanofi
Nov 915:50
Conference pass
Development of tools and ontologies for semantically annotated scientific data for AI and machine learning applications
Data Management, Storage and Architecture
Mark Doerr, Senior Scientist, University Greifswald
Nov 915:50
Conference pass
Standardization and Simplification of Document Management - Holding on to Your Knowledge in an Agile World
Digital Transformation
Roman Engel, Head of Agile Document Flow - VPH, Roche
Nov 915:50
Conference pass
Unblocking the value of data through partnerships
RWE
Meni Styliadou, VP Distinguished Fellow, Data Science Institute, Takeda Europe R&D
Nov 915:50
Conference pass
From single cell to precision medicine
Single Cell Genomics
Panagiotis Chouvardas, PostDoc Researcher Computational Biologist, University of Bern
Nov 915:50
Conference pass
Harnessing the power of omics for precision diagnostics
Companion Diagnostics
Gina Fioretti, Executive Director of Genomics, Recuro Health
Nov 915:50
Conference pass
Using biobank level exome sequencing to study rare diseases
Rare Diseases & NGS
Luke Ward, Associate Director, Human Genetics, Alnylam Pharmaceuticals
Nov 916:40
Conference pass
Chair remarks
Analytics Platforms
Nareen Katta, Head of Clinical Analytics, AbbVie
Nov 916:40
Conference pass
Chair remarks
Data Integration + FAIR
Marco Giannitrapani, VP of Global Data & Analytics - Go To Market, Roche
Nov 916:40
Conference pass
Chair remarks
Digital Transformation
Angelika Fuchs, Head of Discovery Informatics, Roche
Nov 916:40
Conference pass
Chair remarks
RWE
Martina von Meyenn, Global Medical Chapter Lead, Real World Evidence, Roche
Nov 916:45
Conference pass
Real life AI: Opportunities and pitfalls in healthcare
AI in Drug Development
Faisal Khan, Corporate Vice President, Advanced Analytics, AI & RWD, Novo Nordisk
Nov 916:45
Conference pass
Leveraging AI and Big data for new target discovery for Oncology
Big Data in Oncology
Miika Ahdesmaki, Director, Early Computational Oncology, AstraZeneca
Dimitris Polychronopoulos, Associate Director, AstraZeneca
Nov 916:45
Conference pass
Using new technologies to overcome challenges in analytical capabilities
Analytics Platforms
Yang Yang, Principle Scientist, Novartis
Nov 916:45
Conference pass
How the lines between health systems and pharma should be redrawn to allow patient data flow: The platformisation of clinical data
Data Integration + FAIR
Alex Sherman, Director, Center for Innovation and BioInformatics Neurological Clinical Research Institute, Massachusetts General Hospital
Nov 916:45
Conference pass
Integrated data for actionable insights within bioinformatics
Bioinformatics +In Silico R&D
Dennis Madsen, Principal Scientist, Bioinformatics and Data mining, Novo Nordisk A/S
Nov 916:45
Conference pass
NIBR’s Journey to Digitalize Biologics Discovery – Value Chain
Data Management, Storage and Architecture
Bjorn Schuller, Professor of AI & Chair of Embedded Intelligence for Health Care and Wellbeing, Imperial College London
Drazen Nadoveza, Senior Principal Software Engineer, Technical Lead – NIBR Informatics, ENG, Novartis
Nov 916:45
Conference pass
Optimising the data transfer from hospital EHR platforms to sponsor systems
Digital Transformation
Peter Casteleyn, Director Clinical Data Collection Solutions, Janssen
May Govaerts, Head of Clinical Data Solutions – EBIS, Janssen
Nov 916:45
Conference pass
Developing clinically relevant predictive analytic tools from patient, clinical and lab data
RWE
William Paiva, Managing Partner, Oklahoma Life Science Fund
Nov 916:45
Conference pass
Modelling single cell dynamics for immunology
Single Cell Genomics
Ziv Bar-Joseph, Head, R&D Data and Computational Sciences, Sanofi
Nov 916:45
Conference pass
Sample handling strategies for liquid biopsy
Liquid Biopsy
Thomas Valentin, Group Leader - Sample Handling & Sensing, CSEM SA
Nov 916:45
Conference pass
Presentation
Companion Diagnostics
Gurvinder Kenth, Senior Manager, Global Diagnostics Excellence, Astra Zeneca
Nov 916:45
Conference pass
Genetic and pharmacological causes of germline hypermutation
Rare Diseases & NGS
Matthew Neville, PhD Candidate, Wellcome Sanger Institute
Nov 917:05
Conference pass
FAIR in the Swiss personalised health network (SPHN)
Data Integration + FAIR
Sabine Österle, Team Lead Data Interoperability, SIB Swiss Institute of Bioinformatics
Nov 917:25
Conference pass
Panel Discussion: Alliance for Artificial Intelligence in Healthcare: A pre-competitive approach
AI in Drug Development
Angeli Moller, Head of Pharma International Informatics (PIIX), Roche
Nov 917:25
Conference pass
Panel Discussion: The Variations and Inequality in Cancer Care
Big Data in Oncology
Sanjoy Paul, Real World Evidence Leader – Oncology, AstraZeneca
Nov 917:25
Conference pass
Panel Discussion: How do we balance innovation and value generation while enabling analytics capabilities within pharma
Analytics Platforms
Nareen Katta, Head of Clinical Analytics, AbbVie
Carolin Schmuedderich, Head of R&D Digital & Data Transformation, Merck Healthcare KGaA
Xiaoying Wu, Vice President, Data Platforms & Privacy, Data Science, Janssen
Nov 917:25
Conference pass
Panel Discussion: Beyond Usability and 'quick wins' to Embedding Enterprise UX Design
Bioinformatics +In Silico R&D
Jennifer Cham, Product Designer, Enterprise Business Computing, CERN
John Chan, Head, ShinrAI Center for Artificial Intelligence/ Machine Learning, Takeda
Nov 917:25
Conference pass
Panel Discussion: P4 Ecosystems, And Early Stages of Disease
Digital Transformation
Michael Rebhan, Senior Investigator, Novartis Pharma AG
Wen Hwa Lee, Chief Executive Officer, Action Against AMD
Pekka Kahri, Technology Officer, Helsinki Univerisity Hospital
Nov 917:25
Conference pass
Panel Discussion: Strengthening Data, Digital and AI Approaches in Medical Oncology
RWE
Fareed. Mirza, Global Head of Data Alliances, AstraZeneca
Joel Greshock, Vice President of Data Sciences, Oncology, Janssen
Nov 917:25
Conference pass
Panel Discussion: Community standards for integrating genomics with other data types for rare disease patients
Rare Diseases & NGS
Ramona Walls, Associate Director of Data Science, Critical Path Institute
Create your personal agenda –check the favourite icon
Nov 108:35
Conference pass
Chair remarks
Keynotes
Shubha Chaudhari, Head of Clinical Technology Solutions, GSK
Nov 108:40
Conference pass
The future of RWD: Harnessing RWD to accelerate drug development
Keynotes
Christopher Boone, VP, Global Head, Health Economics & Outcomes Research, AbbVie
Nov 108:55
Conference pass
Chair remarks
Plenary - Genomics Live
Paul Nioi, Vice President, Discovery and Translational Research, Alnylam Pharmaceuticals
Nov 109:00
Conference pass
A Computer Science Looks at Discovery Science
Keynotes
Hal Stern, VP & CIO, Pharmaceutical R&D, Janssen
Nov 109:00
Conference pass
Benchmarking ctDNA
Plenary - Genomics Live
Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb
Nov 109:20
Conference pass
What does digital transformation mean for Big Pharma?
Keynotes
Thomas Senderovitz, Senior Vice President, Data Science, Novo Nordisk A/S
Nov 1011:40
Conference pass
Chair remarks
AI in Drug Development
Markus Hinder, Head Patient Safety, Novartis Pharma AG
Nov 1011:40
Conference pass
Chair remarks
Data Management, Storage and Architecture
Susan Gregurick, Associate Director for Data Science, National Institutes of Health
Nov 1011:40
Conference pass
Chair remarks
Digital Transformation
Thomas Jung, Head R&D IT, Syngenta
Nov 1011:40
Conference pass
Chair remarks
RWE
Teddy Sun, Evidence Generation Lead, Takeda
Nov 1011:45
Conference pass
Challenges and opportunities of using AI for drug development
AI in Drug Development
Nuray Yurt, Global Head, Artificial Intelligence (AI) Solutions, Global Data & Digital, Novartis
Nov 1011:45
Conference pass
Beyond Data Strategy Shifting Gears from Data Planning to Data Doing
Data Integration + FAIR
Magdalena Wienken, Associate Director & Team Lead TM Data Ops & Governance, AstraZeneca
Nov 1011:45
Conference pass
Multiblock analysis to predict biomarkers for skin conditions
Bioinformatics +In Silico R&D
Namita Misra, Head, Multi-Omics Data Scientist Team, L'OREAL SA
Nov 1011:45
Conference pass
NIH Strategic Plan for Data Science: Challenges and Opportunities
Data Management, Storage and Architecture
Susan Gregurick, Associate Director for Data Science, National Institutes of Health
Nov 1011:45
Conference pass
What does AI and innovation look like in public health systems
Digital Transformation
Giuseppe Sollazzo, Deputy Director NHS AI Lab, Head of AI Skunkworks & Deployment, NHS England and NHS Improvement
Nov 1011:45
Conference pass
How do you approach your real world evidence data capturing: Big Data vs Targeted Data
RWE
Vidya Breeveld, Founder, Transmineo
Nov 1011:45
Conference pass
Spatial transcriptomics in GI disorders
Single Cell Genomics
Sarah Harris, Head, GI and Neurology Disease Teams, Translational Medicine, Bristol Myers Squibb
Nov 1011:45
Conference pass
The use of liquid biopsies as a monitoring tool for solid tumour indications
Liquid Biopsy
Jan Christoph Brase, Global Biomarker Diagnostic Leader, Novartis
Nov 1011:45
Conference pass
Accelerating precision medicine trials with digital and at-home genomic testing
Rare Diseases & NGS
Patrick Short, Chief Executive Officer, Sano Genetics
Nov 1012:25
Conference pass
Target identification and validation methods, leveraging large-scale cohort data and machine learning
AI in Drug Development
Dimitrios Vitsios, Research Associate, AstraZeneca
Nov 1012:25
Conference pass
Building capacity and bridging gaps: scaling digital technologies and precision medicine in LMICs
Bioinformatics +In Silico R&D
Huguette Diakabana, Co-Lead, WHO Digital Solutions Clearinghouse Workstream, World Health Organisation
Nov 1012:25
Conference pass
Faster and Better: automating data between Electronic Health Records and Electronic Data Capture systems at hospitals
Data Management, Storage and Architecture
Mats Sundgren, Health Data Science Director, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca
Nov 1012:25
Conference pass
Swiss Personalized Health Network: Opportunities and Shared Benefit
Digital Transformation
Urs Frey, President, Swiss Personalized Health Network
Nov 1012:25
Conference pass
Challenges of generating evidence for rare diseases in Europe
RWE
Giovanna Barcelos, HEOR RWE Senior Manager, Europe & GCC, Global Blood Therapeutics
Nov 1012:25
Conference pass
With technology to biology: How single cell methods revolutionize the functional genomics field
Single Cell Genomics
Daniel Schraivogel, Research Staff Scientist, EMBL
Nov 1012:25
Conference pass
Why biobanking is the most important tool for rare disease research
Rare Diseases & NGS
Karine Sargsyan, Managing Director of International Biobanking, Medizinische Universitat Graz
Nov 1012:45
Conference pass
Testing for rare genetic diseases of obesity
Rare Diseases & NGS
Patrick Kleyn, Senior Vice President, Translational Research & Development, Rhythm Pharmaceuticals
Nov 1013:05
Conference pass
Machine learning on GWAS and Biobank data for novel therapeutic translation
AI in Drug Development
Zhihao Ding, Head of Human Genetics, Boehringer-Ingelheim
Nov 1013:05
Conference pass
Data strategy, FAIRification and curation at Roche
Data Integration + FAIR
Silvia Jimenez, Senior Scientist, Roche
Nov 1013:05
Conference pass
Bioinformatics as an enabler for precision medicine
Bioinformatics +In Silico R&D
Daniel Muthas, Head of Data Science & Bioinformatics, AstraZeneca
Nov 1013:05
Conference pass
GA4GH: enabling responsible and effective data use
Data Management, Storage and Architecture
Fabio Liberante, Postdoctoral Fellow, Wellcome Trust Sanger Institute
Maili Raven-Adams, Policy Analyst, Global Alliance for Genomics & Health
Nov 1013:05
Conference pass
How new technologies require new ways of working
Digital Transformation
Joachim Luithle, Vice President – Head of Clinical Operations, Pharma R&D, Bayer
Nov 1013:05
Conference pass
Liquid biopsy in kidney transplant care: A clinician’s perspective
Liquid Biopsy
Bilgin Osmanodja, Physician, Charite
Nov 1013:05
Conference pass
NGS and personalised medicine in solid tumours
Rare Diseases & NGS
Michael Uhlin, Professor Clinical Immunology, Karolinska University Hospital
Nov 1014:25
Conference pass
Chair remarks
AI in Drug Development
Sotirios Perdikeas, Senior Principal Scientist and People Coach, Predictive Modelling and Data Analytics, R&D, Roche
Nov 1014:25
Conference pass
Chair remarks
RWE
Erwan Muros-Le Rouzic, Senior Principal RWD Scientist/Epidemiologist, Roche
Nov 1014:30
Conference pass
Application Of Clinical Genomic Medicine Data to Drug Discovery and Development
AI in Drug Development
Pierre Farmer, Head, in silico Lead Discovery Basel, novartis
Nov 1014:30
Conference pass
Health research data ecosystem
Data Integration + FAIR
Harpreet Singh, Scientist, Indian Council of Medical Research
Nov 1014:30
Conference pass
Harnessing human genetics data for drug discovery
Bioinformatics +In Silico R&D
Emily Wong, Senior Scientist, Computational Biology, Takeda Pharmaceuticals
Nov 1014:30
Conference pass
Lab of the future: Moving towards a more user-centric laboratory
Digital Transformation
Michael Langner, Head of Business Unit, Healthcare Industries, Fraunhofer IPA
Nov 1014:30
Conference pass
Implementation of NGS technology for whole genome sequencing in microbiology
Single Cell Genomics
Dunstan Rajendram, Senior Scientist, UK Health Security Agency
Nov 1014:30
Conference pass
The perfect match: cellular biomarkers demonstrating how APDS has met its therapy
Rare Diseases & NGS
Ulrike Sommer, Senior Principal Scientist, Novartis Institutes for Biomedical Research
Nov 1015:10
Conference pass
Adverse events in the Digital age
AI in Drug Development
Robert Di Giovanni, Global patient safety lead, Novartis Pharma AG
Nov 1015:10
Conference pass
Healthcare Data engineering using graphs
Data Integration + FAIR
Lukasz Kaczmarek, Data Architect, Roche
Andrew Nguyen, Data Architecture & Informatics Capability Lead, Roche Real World Data Hub, Genetech
Nov 1015:10
Conference pass
Using observational data to support biomarker rationale
Bioinformatics +In Silico R&D
Moritz Saxenhofer, Senior Translational Scientist, CSL Behring
Nov 1015:10
Conference pass
Developing digital capabilities to support the commercial needs of a pharma company
Digital Transformation
Florent Hassen, Global Data Science & Artificial Intelligence Lead, Roche
Nov 1015:10
Conference pass
Using single cell genomics to identify targets for metastasis and therapy resistance in breast cancer
Single Cell Genomics
Vijay Tiwari, Professor and Group Head, Genomics and Data Science in Precision Medicine Laboratory, Wellcome-Wolfson Institute For Experimental Medicine, Queen's University Belfast
Nov 1015:10
Conference pass
Safety of gene therapy for rare diseases
Rare Diseases & NGS
Saumyaa Saumyaa, Senior Research Scientist, Astra Zeneca
Nov 1015:50
Conference pass
Demonstrating how ‘Big Pharma’ can successfully transform it’s R&D activities using data & advanced analytics/AI from drug discovery through to regulatory submissions
AI in Drug Development
Eric Genevois-Marlin, Head of RD Data and Data Sciences (DDS), Sanofi
Nov 1015:50
Conference pass
Informatics ecosystems supporting FAIR data integration in clinical studies
Data Integration + FAIR
Holmfridur Thorsteinsdottir, Head Clinical & Biomarker Informatics, Roche
Nov 1015:50
Conference pass
Interrogating AAV genome integrity with PacBio sequencing
Bioinformatics +In Silico R&D
Ge Tan, Senior Expert, Data Science, Novartis Institutes for Biomedical Research
Nov 1015:50
Conference pass
Moving to Next Generation Market Access Through Data and Digital Technologies
Digital Transformation
Thorsten Rall, Global Head Digital Transformation & Innovation, SVP, Novartis
Nov 1015:50
Conference pass
Proteomics analysis in SLE and Sjogren 's syndrome
Rare Diseases & NGS
Andrea Grioni, Senior Data Scientist, Novartis Institutes for Biomedical Research
last published: 30/Jun/22 10:56 GMT
Get involved at BioTechX
TO SPONSOR
Alistair Wilmot
alistair.wilmot@terrapinn.com
Danielle Thomas
danielle.thomas@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events